AB Evans, AJ Al-Himyary, MI Hrovat, P Pappagianopoulos, JC Wain, LC Ginns and DM Systrom
Pulmonary and Critical Care Unit, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.

Although lung transplantation improves exercise capacity by removal of a ventilatory limitation, recipients' postoperative maximum oxygen uptake (VO2max) remains markedly abnormal. To determine if abnormal skeletal muscle oxidative capacity contributes to this impaired aerobic capacity, nine lung transplant recipients and eight healthy volunteers performed incremental quadriceps exercise to exhaustion with simultaneous measurements of pulmonary gas exchange, minute ventilation, blood lactate, and quadriceps muscle pH and phosphorylation potential by 31P-magnetic resonance spectroscopy (31P- MRS). Five to 38 mo after lung transplantation, peak VO2 was decreased compared with that of normal control subjects (6.7 +/- 0.4 versus 12.3 +/- 1.0 ml/min/kg, p < 0.001), even after accounting for differences in age and lean body weight. Neither ventilation, arterial O2 saturation nor mild anemia could account for the decrease in aerobic capacity. Quadriceps muscle intracellular pH (pH(i)) was more acidic at rest (7.07 +/- 0.01 versus 7.12 +/- 0.01 units, p < 0.05) and fell during exercise from baseline values at a lower metabolic rate (282 +/- 21 versus 577 +/- 52 ml/min, p < 0.001). Regressions for pH(i) versus VO2, phosphocreatine/inorganic phosphate ratio (PCr/Pi) versus VO2, and blood lactate versus pH(i) were not different. Among transplant recipients, the metabolic rate at which pH(i) fell correlated closely with VO2max (r = 0.87, p < 0.01). The persistent decrease in VO2max after lung transplantation may be related to abnormalities of skeletal muscle oxidative capacity.

This article has been cited by other articles:

				K. Guerrero, B. Wuyam, P. Mezin, I. Vivodtzev, M. Vendelin, J.-C. Borel, R. Hacini, O. Chavanon, S. Imbeaud, V. Saks, et al. Functional coupling of adenine nucleotide translocase and mitochondrial creatine kinase is enhanced after exercise training in lung transplant skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1144 - R1154. [Abstract] [Full Text] [PDF]

				S. Mathur, W D. Reid, and R. D Levy Exercise Limitation in Recipients of Lung Transplants Physical Therapy, December 1, 2004; 84(12): 1178 - 1187. [Full Text] [PDF]

				S.M. Studer, R.D. Levy, K. McNeil, and J.B. Orens Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness Eur. Respir. J., October 1, 2004; 24(4): 674 - 685. [Abstract] [Full Text] [PDF]

				C Pinet, P Scillia, M Cassart, M Lamotte, C Knoop, C Melot, and M Estenne Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis Thorax, September 1, 2004; 59(9): 783 - 789. [Abstract] [Full Text] [PDF]

				M. J. McKenna, S. F. Fraser, J. L. Li, X. N. Wang, M. F. Carey, E. A. Side, J. Morton, G. I. Snell, K. Kjeldsen, and T. J. Williams Impaired muscle Ca2+ and K+ regulation contribute to poor exercise performance post-lung transplantation J Appl Physiol, October 1, 2003; 95(4): 1606 - 1616. [Abstract] [Full Text] [PDF]

				F. Laghi and M. J. Tobin Disorders of the Respiratory Muscles Am. J. Respir. Crit. Care Med., July 1, 2003; 168(1): 10 - 48. [Abstract] [Full Text] [PDF]

				ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF]

				A. Berakis, T. J. Williams, M. T. Naughton, J. H. Martin, M. Muhlmann, and H. Krum Altered Sympathetic and Parasympathetic Activity in Lung Transplantation Patients at Rest and Following Autonomic Perturbation Chest, October 1, 2002; 122(4): 1192 - 1199. [Abstract] [Full Text] [PDF]

				A. Somfay, J. Porszasz, S.-M. Lee, and R. Casaburi Effect of Hyperoxia on Gas Exchange and Lactate Kinetics Following Exercise Onset in Nonhypoxemic COPD Patients Chest, February 1, 2002; 121(2): 393 - 400. [Abstract] [Full Text] [PDF]

				H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047. [Abstract] [Full Text] [PDF]

				J. G. PANTOJA, F. H. ANDRADE, A. E. FROST, W. L. ESCHENBACHER, and M. B. REID Respiratory and Limb Muscle Function in Lung Allograft Recipients Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1205 - 1211. [Abstract] [Full Text]

				X. N. WANG, T. J. WILLIAMS, M. J. MCKENNA, J. L. LI, S. F. FRASER, E. A. SIDE, G. I. SNELL, E. H. WALTERS, and M. F. CAREY Skeletal Muscle Oxidative Capacity, Fiber Type, and Metabolites after Lung Transplantation Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 57 - 63. [Abstract] [Full Text]

				S. M. Arcasoy and R. M. Kotloff Lung Transplantation N. Engl. J. Med., April 8, 1999; 340(14): 1081 - 1091. [Full Text] [PDF]

				Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease . A Statement of the American Thoracic Society and European Respiratory Society Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): S2 - 40. [Full Text] [PDF]

				B. J. Whipp, H. B. Rossiter, S. A. Ward, D. Avery, V. L. Doyle, F. A. Howe, and J. R. Griffiths Simultaneous determination of muscle 31P and O2 uptake kinetics during whole body NMR spectroscopy J Appl Physiol, February 1, 1999; 86(2): 742 - 747. [Abstract] [Full Text] [PDF]

				M. S. Biring, M. Fournier, D. J. Ross, and M. I. Lewis Cellular adaptations of skeletal muscles to cyclosporine J Appl Physiol, June 1, 1998; 84(6): 1967 - 1975. [Abstract] [Full Text] [PDF]

				D. A. Oelberg, A. B. Evans, M. I. Hrovat, P. P. Pappagianopoulos, S. Patz, and D. M. Systrom Skeletal muscle chemoreflex and pHi in exercise ventilatory control J Appl Physiol, February 1, 1998; 84(2): 676 - 682. [Abstract] [Full Text] [PDF]